Cellid Co. Ltd
Cellid, Co., Ltd. develops immunotherapeutic vaccines for cancer and/or infectious diseases therapies. It is developing BVAC-C for cervical, head and neck, anal, and sex organ cancer with human papilloma virus infection; BVAC-B for stomach, breast, and ovarian cancer with HER-2/neu antigen; and BVAC-P for prostate cancer, renal cell cancer, and glioblastoma with prostate acid phosphatase (PAP) an… Read more
Cellid Co. Ltd (299660) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: -0.047x
Based on the latest financial reports, Cellid Co. Ltd (299660) has a cash flow conversion efficiency ratio of -0.047x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩-3.71 Billion) by net assets (₩78.71 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cellid Co. Ltd - Cash Flow Conversion Efficiency Trend (2016–2024)
This chart illustrates how Cellid Co. Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Cellid Co. Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Cellid Co. Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Farmsco
KO:036580
|
-0.006x |
|
Berentzen Gruppe AG
XETRA:BEZ
|
-0.079x |
|
IBKS No. 15 Special Purpose Acquisition Co. Ltd.
KQ:373200
|
-0.554x |
|
Saraswanti Anugerah Makmur Pt
JK:SAMF
|
0.243x |
|
Chuong Duong Corp
VN:CDC
|
N/A |
|
TEAM INC. DL-30
F:T9CA
|
N/A |
|
Coincheck Group N.V. Ordinary Shares
PINK:CNCK
|
-0.128x |
|
Zoomd Technologies Ltd
PINK:ZMDTF
|
0.186x |
Annual Cash Flow Conversion Efficiency for Cellid Co. Ltd (2016–2024)
The table below shows the annual cash flow conversion efficiency of Cellid Co. Ltd from 2016 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | ₩51.20 Billion | ₩-10.32 Billion | -0.201x | -14.66% |
| 2023-12-31 | ₩40.50 Billion | ₩-7.12 Billion | -0.176x | +67.73% |
| 2022-12-31 | ₩22.44 Billion | ₩-12.22 Billion | -0.544x | -157.14% |
| 2021-12-31 | ₩38.76 Billion | ₩-8.21 Billion | -0.212x | -166.09% |
| 2020-12-31 | ₩47.30 Billion | ₩-3.76 Billion | -0.080x | -112.62% |
| 2019-12-31 | ₩51.33 Billion | ₩-1.92 Billion | -0.037x | +74.67% |
| 2018-12-31 | ₩13.50 Billion | ₩-1.99 Billion | -0.148x | -159.53% |
| 2017-12-31 | ₩-5.53 Billion | ₩-1.37 Billion | 0.248x | -96.60% |
| 2016-12-31 | ₩-205.83 Million | ₩-1.50 Billion | 7.306x | -- |